The activation of phosphatidylinositol 3-kinase (PI 3-K) and subsequent production of PtdIns(3,4,5) P 3 launches a signal transduction cascade that impinges on a plethora of downstream effects on cell physiology. Control of PI 3-K and PtdIns(3,4,5)P 3 levels are important therapeutic targets in treatments for allergy, inflammation, cardiovascular, and malignant human diseases. We designed metabolically-stabilized, i.e., phosphatase resistant, analogues of PtdIns(3,4,5)P 3 as probes for longlived potential agonists or potentially antagonists for cellular events mediated by of PtdIns(3,4,5) P 3 . In particular, two types of analogues were prepared containing phosphomimetics that would be selectively resistant to the lipid 3-phosphatase PTEN. The total asymmetric synthesis of the 3-phosphorothioate-PtdIns(3,4,5)P 3 and 3-methylenephosphonate-PtdIns(3,4,5)P 3 analogues is described. These two analogues showed differential binding to PtdIns(3,4,5)P 3 binding modules, and both were potential long-lived activators that mimicked insulin action in sodium transport in A6 cells.The phosphoinositide 3-kinase (PI 3-K) signaling pathway contains important therapeutic targets in human pathophysiology. 1,2 Phosphatidylinositol-3,4,5 -triphosphate (PtdIns(3,4,5) P 3 ) is a ubiquitous signaling lipid found in higher eukaryotic cells 3 and activates a plethora of downstream cellular processes. 4 These signaling events include cell proliferation and transformation, 5 cell shape and motility, 6 and insulin action and alteration of glucose transport. 7 PtdIns(3,4,5)P 3 -regulated signaling is modulated by the lipid 3-phosphatase PTEN 8 and SH2 domain-containing inositol 5-phosphatase SHIP. 9A metabolically-stabilized (ms) analogue of PtdIns(3,4,5)P 3 that resists lipid 3-and 5-phosphatases would have numerous applications in understanding the role of PtdIns(3,4,5)P 3 in cell physiology. The ms-PtdIns(3,4,5)P 3 analogues could separate the activation of signal transduction from the degradation of the signal by phosphatase action in cells. This chemical biology approach to dissection of the PI 3-K pathway is complementary to the use of siRNA knockdowns or genetic knockouts for PTEN and SHIP. We focused first on a 3-stabilized PtdIns(3,4,5)P 3 analog, i.e., one resistant to hydrolysis by PTEN, and we selected two stabilized phosphomimetic isosteres to replace the 3-phosphate of PtdIns(3,4,5)P 3 .gprestwich@pharm.utah.edu. Phosphorothioates are phosphomimetics that show reduced rates of enzyme-mediated hydrolysis. 10 However, the replacement of P = O by P = S also affects the pKa of the phosphate and removes a H-bond acceptor. 11,12 For example, the phosphorothioate analogue of PtdIns (3)P had reduced binding activity for cognate binding proteins, due in part to reduced Hbonding. 13 We hypothesized that a 3-phosphorothioate of PtdIns(3,4,5)P 3 could be either an antagonist or a long-lived agonist in the PI 3-K signaling pathway, because of reduced dephosphorylation by PTEN. Moreover, the methylenephosphonate analogue of PtdIns(3)...